Literature DB >> 21731126

The need for pharmacovigilance in sleep medicine.

Sairam Parthasarathy1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21731126      PMCID： PMC3119823          DOI： 10.5665/SLEEP.1096

Source DB:  PubMed          Journal:  Sleep        ISSN： 0161-8105            Impact factor:   5.849


× No keyword cloud information.
  11 in total

1.  Benzodiazepine use and risk of mortality in individuals aged 85 years or older.

Authors:  David J Vinkers; Jacobijn Gussekloo; Roos C van der Mast; Frans G Zitman; Rudi G J Westendorp
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

2.  Failing the public health--rofecoxib, Merck, and the FDA.

Authors:  Eric J Topol
Journal:  N Engl J Med       Date:  2004-10-06       Impact factor: 91.245

3.  Mortality associated with sleep duration and insomnia.

Authors:  Daniel F Kripke; Lawrence Garfinkel; Deborah L Wingard; Melville R Klauber; Matthew R Marler
Journal:  Arch Gen Psychiatry       Date:  2002-02

4.  Practice parameters for the nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine.

Authors:  A L Chesson; W M Anderson; M Littner; D Davila; K Hartse; S Johnson; M Wise; J Rafecas
Journal:  Sleep       Date:  1999-12-15       Impact factor: 5.849

5.  Hypnotics, sleep, and mortality in elderly people.

Authors:  R Rumble; K Morgan
Journal:  J Am Geriatr Soc       Date:  1992-08       Impact factor: 5.562

6.  Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia.

Authors:  Jasmanda H Wu; David H Howard; John E McGowan; Lourdes M Frau; Wanju S Dai
Journal:  Clin Ther       Date:  2004-12       Impact factor: 3.393

Review 7.  Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors:  D Mukherjee; S E Nissen; E J Topol
Journal:  JAMA       Date:  2001 Aug 22-29       Impact factor: 56.272

8.  Who is a candidate for cognitive-behavioral therapy for insomnia?

Authors:  Michael T Smith; Michael L Perlis
Journal:  Health Psychol       Date:  2006-01       Impact factor: 4.267

9.  Sedating medications and undiagnosed obstructive sleep apnea: physician determinants and patient consequences.

Authors:  Brandon Lu; Rohit Budhiraja; Sairam Parthasarathy
Journal:  J Clin Sleep Med       Date:  2005-10-15       Impact factor: 4.062

10.  Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study.

Authors:  J Pericás; A Muñoz; L Findley; J M Antó; A G Agustí
Journal:  Am J Respir Crit Care Med       Date:  1998-07       Impact factor: 21.405
View more
  2 in total

1.  Past-year use or misuse of an opioid is associated with use of a sedative-hypnotic medication: a US National Survey on Drug Use and Health (NSDUH) study.

Authors:  Andrew S Tubbs; Sadia B Ghani; Michelle Naps; Michael A Grandner; Michael D Stein; Subhajit Chakravorty
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.324

2.  Prescription medications for insomnia are associated with suicidal thoughts and behaviors in two nationally representative samples.

Authors:  Andrew S Tubbs; Fabian-Xosé Fernandez; Sadia B Ghani; Jordan F Karp; Salma I Patel; Sairam Parthasarathy; Michael A Grandner
Journal:  J Clin Sleep Med       Date:  2021-05-01       Impact factor: 4.062
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.